Physician profile
Vinod V Pathy
NPI 1922299098
$2,418.50
in general payments reported to CMS, 2019-2025
17 companies · $728 in 2025
The $728 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606 · 2020: $107 · 2021: $129 · 2023: $288 · 2024: $560 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,575.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $607.94 | 2023-2025 | |
| Medical Device Business Services, INC. | $514.55 | 2019 | |
| Mentor Worldwide LLC | $243.43 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $175.28 | 2019-2021 | |
| Tela Bio, INC. | $162.29 | 2024 | Ovitex 2s |
| Musculoskeletal Transplant Foundation INC. | $140.28 | 2023-2025 | |
| Motiva USA, LLC | $139.55 | 2024-2025 | |
| Allergan, INC. | $104.06 | 2019-2021 | |
| Innovation Technologies INC | $95.39 | 2023 | Irrisept |
| Axogen | $58.13 | 2025 | |
| Vioptix INC | $35.76 | 2024 | T. Ox Tissue Oximeter |
| W. L. Gore & Associates, INC. | $30.53 | 2025 | Gore Synecor Preperitoneal Biomaterial |
| Integra Lifesciences Corporation | $27.88 | 2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Medtronic, INC. | $25.79 | 2023 | V-Loc 180 |
| Biocomposites INC | $22.52 | 2025 | Stimulan |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $18.82 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $16.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinod Pathy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.